Opinion

Mosthealthcareexperts agree that Patient compliance has been a problem for as long as pharmaceutical treatments have been prescribed to people. Unfortunately, consumers, patients and caregiversthink they are good medicine takers, so how and why should they change? What is the problem? Therein lies the solution!!!

Over the years, many patient compliance interventions have been developed, yet no single platform or approach has been adopted or widely accepted and the solution to most compliance, adherence and persistence problems remains untested.Industry expertsagree that Disease Management (DM) and Medication Therapy Management (MTM) programsbenefit the patient by improving treatment outcomes and reducing Adverse Drug Events (ADE's). UnfortunatelyDM and MTMprograms are cost prohibitive and labor intensive so widespread adoptionseems unlikely. Plus,DM and MTM cannoteffectively solve the most common problems in Pharmaceutical care across all socio-economic strata.WhenDrug Stores and Pharmaceutical manufacturersproperly present the Adherence problem to consumers,they canseize the opportunity to improve customer satisfaction and patient outcomes while simultaneously reducing Adverse Drug Events (ADE).

There may notbe asolution to all problemsin every situation, but the"Gold Standard" for improving patient compliance, adherence and persistencedoes exist and can cost effectively solve the most common, yet challenging causes of the problem while overcoming common treatment barriers, regardless of race, education, income and language... for less than the cost of a candy bar. P

Patient compliance, adherence and persistencecan bethe nextblockbuster treatment yet remainsan untapped "Golden Goose" for industry.